1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Crump, M.P.
Elisseeva, E.
Gong, J.-H.
Clark-Lewis, I.
Sykes, B.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
489
171
10.1016/S0014-5793(00)02393-0
11165244
Structure/Function of Human Herpesvirus-8 Mip-II (1-71) and the Antagonist N-Terminal Segment (1-10)
2001
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
8142.661
VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
RESIDUES 1-71
1
syn
polymer
VMIP-II, VMIP-1B
no
no
LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR
LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
1
0
2001-01-07
1
1
2011-05-08
1
2
2011-07-13
NMR SOLUTION STRUCTURES OF THE VMIP-II 1-71 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. NMR, MINIMISED AVERAGE STRUCTURE
NMR SOLUTION STRUCTURES OF THE VMIP-II 1-10 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. (RESIDUES 1-10 55 STRUCTURES)
CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II
PDBE
Y
PDBE
2000-12-07
REL
37296
HUMAN HERPESVIRUS 8
sample
SEE 1HFG FOR MINIMIZED AVERAGE STRUCTURE. SEE PAPER FOR FURTHER EXPERIMENTAL DETAILS.
LEAST RESTRAINT VIOLATION
38
38
DQF-COSY
TOCSY
NOESY
5.0
pH
1
atm
303
K
REFINEMENT DETAILS CAN BE FOUND IN THE JOURNAL CITATION.
simulated annealing
1MM DSS, 1MM NAN3, 20MM SODIUM ACETATE
BRUNGER
refinement
X-PLOR
structure solution
X-PLOR
600
Varian
UNITY
LEU
1
n
1
LEU
1
A
GLY
2
n
2
GLY
2
A
ALA
3
n
3
ALA
3
A
SER
4
n
4
SER
4
A
TRP
5
n
5
TRP
5
A
HIS
6
n
6
HIS
6
A
ARG
7
n
7
ARG
7
A
PRO
8
n
8
PRO
8
A
ASP
9
n
9
ASP
9
A
LYS
10
n
10
LYS
10
A
CYS
11
n
11
CYS
11
A
CYS
12
n
12
CYS
12
A
LEU
13
n
13
LEU
13
A
GLY
14
n
14
GLY
14
A
TYR
15
n
15
TYR
15
A
GLN
16
n
16
GLN
16
A
LYS
17
n
17
LYS
17
A
ARG
18
n
18
ARG
18
A
PRO
19
n
19
PRO
19
A
LEU
20
n
20
LEU
20
A
PRO
21
n
21
PRO
21
A
GLN
22
n
22
GLN
22
A
VAL
23
n
23
VAL
23
A
LEU
24
n
24
LEU
24
A
LEU
25
n
25
LEU
25
A
SER
26
n
26
SER
26
A
SER
27
n
27
SER
27
A
TRP
28
n
28
TRP
28
A
TYR
29
n
29
TYR
29
A
PRO
30
n
30
PRO
30
A
THR
31
n
31
THR
31
A
SER
32
n
32
SER
32
A
GLN
33
n
33
GLN
33
A
LEU
34
n
34
LEU
34
A
CYS
35
n
35
CYS
35
A
SER
36
n
36
SER
36
A
LYS
37
n
37
LYS
37
A
PRO
38
n
38
PRO
38
A
GLY
39
n
39
GLY
39
A
VAL
40
n
40
VAL
40
A
ILE
41
n
41
ILE
41
A
PHE
42
n
42
PHE
42
A
LEU
43
n
43
LEU
43
A
THR
44
n
44
THR
44
A
LYS
45
n
45
LYS
45
A
ARG
46
n
46
ARG
46
A
GLY
47
n
47
GLY
47
A
ARG
48
n
48
ARG
48
A
GLN
49
n
49
GLN
49
A
VAL
50
n
50
VAL
50
A
CYS
51
n
51
CYS
51
A
ALA
52
n
52
ALA
52
A
ASP
53
n
53
ASP
53
A
LYS
54
n
54
LYS
54
A
SER
55
n
55
SER
55
A
LYS
56
n
56
LYS
56
A
ASP
57
n
57
ASP
57
A
TRP
58
n
58
TRP
58
A
VAL
59
n
59
VAL
59
A
LYS
60
n
60
LYS
60
A
LYS
61
n
61
LYS
61
A
LEU
62
n
62
LEU
62
A
MET
63
n
63
MET
63
A
GLN
64
n
64
GLN
64
A
GLN
65
n
65
GLN
65
A
LEU
66
n
66
LEU
66
A
PRO
67
n
67
PRO
67
A
VAL
68
n
68
VAL
68
A
THR
69
n
69
THR
69
A
ALA
70
n
70
ALA
70
A
ARG
71
n
71
ARG
71
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
SER
27
A
O
SER
27
A
N
LEU
43
A
N
LEU
43
A
O
VAL
40
A
O
VAL
40
A
N
ALA
52
A
N
ALA
52
13
A
A
O
H
LEU
LEU
62
66
1.60
22
A
A
HZ1
OE1
LYS
GLN
10
49
1.58
1
A
ALA
3
-96.73
-70.15
1
A
SER
4
-176.52
92.65
1
A
HIS
6
61.01
110.18
1
A
ARG
7
-174.66
82.69
1
A
ASP
9
69.46
-67.85
1
A
LYS
10
-178.63
-75.56
1
A
CYS
11
58.68
107.34
1
A
SER
26
-129.90
-64.10
1
A
LYS
56
-60.16
-175.20
1
A
PRO
67
-78.84
-78.56
1
A
VAL
68
172.13
163.85
2
A
ALA
3
-172.51
-68.82
2
A
SER
4
-140.84
-70.63
2
A
TRP
5
-172.60
123.02
2
A
HIS
6
-153.26
-70.71
2
A
ASP
9
-176.70
48.61
2
A
LYS
10
-99.55
31.77
2
A
SER
26
-133.32
-68.33
2
A
LYS
56
-60.41
-174.32
2
A
PRO
67
-79.47
-79.56
2
A
VAL
68
168.98
156.39
2
A
ALA
70
60.79
109.78
3
A
ARG
7
-163.16
85.93
3
A
LYS
10
-161.16
32.12
3
A
CYS
11
-61.88
-173.02
3
A
CYS
12
-102.63
79.77
3
A
LYS
37
-162.06
78.53
3
A
LYS
56
-61.77
-175.88
3
A
PRO
67
-78.18
-78.93
3
A
VAL
68
177.63
163.34
4
A
ASP
9
-165.71
81.64
4
A
LYS
10
-176.67
38.25
4
A
CYS
11
-61.74
-174.67
4
A
SER
26
-130.97
-58.25
4
A
LYS
56
-59.84
-174.30
4
A
ASP
57
-97.02
-64.83
4
A
PRO
67
-78.39
-84.85
4
A
VAL
68
176.56
140.32
5
A
ALA
3
60.66
93.06
5
A
HIS
6
-164.77
-44.91
5
A
ARG
7
-151.29
87.48
5
A
ASP
9
-68.13
83.43
5
A
LYS
10
-177.66
-64.96
5
A
CYS
11
-101.48
74.06
5
A
LYS
17
88.17
-41.52
5
A
SER
36
58.31
19.19
5
A
LYS
37
-170.32
64.60
5
A
LYS
56
-61.00
-174.22
5
A
PRO
67
-76.71
-83.02
5
A
VAL
68
177.49
166.04
6
A
ALA
3
60.68
88.57
6
A
SER
4
60.67
178.19
6
A
ARG
7
60.42
88.06
6
A
LYS
10
-178.59
-40.42
6
A
CYS
12
-178.75
120.66
6
A
SER
36
69.61
-66.85
6
A
LYS
56
-67.40
-172.73
6
A
PRO
67
-76.93
-82.85
6
A
VAL
68
177.12
164.55
6
A
ALA
70
60.77
166.02
7
A
TRP
5
-146.12
40.05
7
A
CYS
11
59.11
107.99
7
A
SER
26
-123.13
-63.66
7
A
LYS
37
-159.99
71.85
7
A
LYS
56
-60.93
-177.32
7
A
ASP
57
-99.37
-60.37
7
A
PRO
67
-76.77
-82.19
7
A
VAL
68
178.67
167.63
7
A
ALA
70
60.57
94.11
8
A
SER
4
55.22
-177.39
8
A
TRP
5
-171.82
143.10
8
A
ASP
9
-177.72
-40.63
8
A
CYS
12
66.16
113.09
8
A
LYS
17
88.40
-43.79
8
A
SER
26
-130.32
-68.34
8
A
SER
32
-62.29
-99.40
8
A
GLN
33
177.30
-40.77
8
A
LEU
34
-97.22
38.65
8
A
CYS
35
-98.61
33.02
8
A
SER
36
69.69
-65.52
8
A
LYS
56
-60.28
-178.13
8
A
PRO
67
-77.78
-78.64
8
A
VAL
68
177.65
163.15
8
A
ALA
70
-170.43
-52.01
9
A
SER
4
60.63
168.33
9
A
TRP
5
62.43
115.22
9
A
HIS
6
-66.18
84.95
9
A
CYS
12
65.50
-73.38
9
A
SER
26
-133.12
-58.02
9
A
SER
36
68.82
-68.91
9
A
LYS
56
-60.61
-176.82
9
A
PRO
67
-77.61
-81.96
9
A
THR
69
-58.48
176.60
10
A
ALA
3
60.78
109.75
10
A
LYS
10
-168.42
34.30
10
A
CYS
11
-62.08
-174.26
10
A
ARG
18
-170.56
147.51
10
A
SER
26
-106.79
-66.45
10
A
CYS
35
-106.95
-73.02
10
A
SER
36
-174.84
-41.80
10
A
LYS
37
-166.84
63.71
10
A
LYS
56
-60.33
-174.06
10
A
PRO
67
-77.06
-82.85
10
A
VAL
68
177.52
153.87
10
A
ALA
70
-173.09
-65.48
11
A
ALA
3
-177.29
99.92
11
A
SER
4
60.60
106.14
11
A
ARG
7
174.98
-54.83
11
A
LYS
17
86.81
-45.19
11
A
SER
26
-131.47
-67.52
11
A
CYS
35
-61.52
-170.97
11
A
LYS
37
-170.65
63.81
11
A
LYS
56
-58.57
177.37
11
A
PRO
67
-79.23
-79.01
11
A
VAL
68
169.73
154.26
11
A
THR
69
-61.45
89.14
11
A
ALA
70
-64.02
84.82
12
A
ALA
3
69.01
-68.36
12
A
SER
4
55.64
171.34
12
A
TRP
5
-164.93
32.70
12
A
ASP
9
60.79
96.54
12
A
CYS
12
61.98
115.55
12
A
SER
26
-128.57
-74.85
12
A
LEU
34
-152.04
48.61
12
A
CYS
35
-115.27
-72.34
12
A
SER
36
-179.81
-43.38
12
A
LYS
37
-170.08
62.83
12
A
LYS
56
-59.90
-176.65
12
A
PRO
67
-78.64
-78.64
12
A
VAL
68
172.61
163.11
12
A
ALA
70
-175.43
95.60
13
A
SER
4
-80.70
-70.73
13
A
HIS
6
-177.50
82.13
13
A
ARG
7
60.81
158.93
13
A
LYS
17
86.10
-43.82
13
A
SER
26
-126.61
-67.06
13
A
CYS
35
-103.27
-73.36
13
A
SER
36
178.84
-39.67
13
A
LYS
37
-162.08
64.28
13
A
LYS
56
-60.77
-178.09
13
A
PRO
67
-78.73
-86.18
13
A
VAL
68
172.21
131.82
14
A
ARG
7
60.45
85.45
14
A
ASP
9
60.60
109.16
14
A
LYS
10
-176.43
-66.58
14
A
CYS
11
-63.09
-179.35
14
A
CYS
12
178.84
116.88
14
A
SER
26
-126.38
-66.85
14
A
LYS
56
-62.31
-175.92
14
A
PRO
67
-77.83
-85.91
14
A
VAL
68
176.19
146.15
14
A
ALA
70
61.08
157.36
15
A
ALA
3
-146.78
32.64
15
A
HIS
6
-107.51
-64.92
15
A
LYS
10
-175.09
93.00
15
A
SER
26
-124.12
-69.52
15
A
LYS
56
-58.39
-176.71
15
A
PRO
67
-75.19
-82.97
15
A
VAL
68
179.41
172.64
15
A
ALA
70
-62.21
-70.95
16
A
ALA
3
-172.96
127.06
16
A
SER
4
60.72
170.67
16
A
CYS
11
-55.16
-173.76
16
A
LEU
13
70.42
-66.43
16
A
ARG
18
-173.43
146.24
16
A
LYS
56
-59.39
-173.29
16
A
PRO
67
-78.55
-78.77
16
A
VAL
68
171.69
163.39
17
A
TRP
5
69.79
-66.58
17
A
HIS
6
-62.37
-70.77
17
A
LYS
10
-155.80
-46.11
17
A
CYS
12
58.94
106.23
17
A
LYS
17
85.75
-45.11
17
A
SER
26
-131.39
-73.57
17
A
CYS
35
-59.83
-174.57
17
A
LYS
56
-59.19
-178.04
17
A
PRO
67
-76.72
-85.48
17
A
VAL
68
178.19
161.70
17
A
ALA
70
60.60
97.45
18
A
SER
4
-99.66
-61.50
18
A
TRP
5
60.88
157.65
18
A
LYS
10
66.88
-71.16
18
A
CYS
11
-61.23
-173.21
18
A
SER
26
-109.50
-67.49
18
A
SER
36
69.86
-61.69
18
A
CYS
51
-69.61
97.18
18
A
LYS
56
-65.15
-177.97
18
A
PRO
67
-76.90
-83.03
18
A
VAL
68
178.48
172.05
18
A
ALA
70
-166.15
33.34
19
A
TRP
5
60.72
167.56
19
A
HIS
6
60.38
84.57
19
A
LYS
10
-70.96
-166.53
19
A
LYS
56
-60.22
-173.05
19
A
PRO
67
-77.47
-81.27
19
A
VAL
68
164.04
156.55
19
A
ALA
70
60.62
166.43
20
A
SER
4
69.30
-62.30
20
A
TRP
5
-68.11
82.40
20
A
HIS
6
-177.81
122.17
20
A
ARG
7
174.89
-53.45
20
A
ASP
9
-75.75
-70.99
20
A
LYS
10
-150.45
30.69
20
A
CYS
11
-61.82
-172.27
20
A
SER
26
-98.42
-66.40
20
A
LYS
56
-61.50
-174.63
20
A
ASP
57
-100.18
-62.33
20
A
VAL
68
120.62
156.66
20
A
ALA
70
65.41
-77.26
21
A
SER
4
60.63
93.00
21
A
HIS
6
-177.65
102.80
21
A
ARG
7
60.41
165.53
21
A
LYS
10
69.71
-65.67
21
A
CYS
12
61.59
113.21
21
A
SER
26
-122.83
-66.64
21
A
LYS
37
-170.03
73.52
21
A
LYS
56
-68.10
-175.83
21
A
PRO
67
-76.63
-84.62
21
A
VAL
68
179.79
170.26
21
A
ALA
70
-178.09
-70.64
22
A
HIS
6
60.81
102.08
22
A
CYS
11
-61.67
-174.39
22
A
SER
26
-124.44
-54.84
22
A
SER
27
-174.03
-167.56
22
A
SER
32
-57.96
177.24
22
A
LEU
34
-72.79
-83.41
22
A
SER
36
69.14
-68.74
22
A
PRO
38
-76.30
-166.51
22
A
ALA
52
-170.03
135.60
22
A
LYS
56
-57.80
-177.27
22
A
ASP
57
-96.57
-65.34
22
A
VAL
68
113.52
152.57
22
A
ALA
70
-160.36
105.22
23
A
ASP
9
-68.12
-76.48
23
A
LYS
10
-179.00
38.19
23
A
CYS
12
60.99
78.48
23
A
LYS
17
87.21
-41.96
23
A
SER
26
-133.94
-71.53
23
A
LYS
56
-60.79
-173.83
23
A
PRO
67
-77.16
-83.84
23
A
VAL
68
177.18
139.44
24
A
SER
4
-169.24
96.27
24
A
TRP
5
60.83
107.86
24
A
HIS
6
-178.75
107.84
24
A
ARG
7
-171.65
88.51
24
A
CYS
11
-59.59
-174.06
24
A
CYS
12
-178.75
90.68
24
A
SER
26
-127.62
-67.36
24
A
SER
36
69.93
-62.08
24
A
LYS
56
-62.09
-175.86
24
A
PRO
67
-78.35
-79.15
24
A
VAL
68
176.10
161.49
24
A
ALA
70
-160.17
32.91
25
A
ALA
3
-174.36
114.98
25
A
SER
4
-163.09
32.89
25
A
LYS
10
-167.49
33.93
25
A
CYS
11
-62.55
-172.92
25
A
ARG
18
-173.47
147.80
25
A
SER
26
-129.32
-67.40
25
A
GLN
33
-99.23
41.99
25
A
LEU
34
-151.72
48.03
25
A
SER
36
70.96
-65.10
25
A
LYS
37
-118.73
79.95
25
A
LYS
56
-58.95
-173.89
25
A
PRO
67
-76.67
-85.12
25
A
VAL
68
177.11
139.14
25
A
ALA
70
-69.50
-172.53
26
A
SER
4
-177.36
117.21
26
A
ARG
7
60.48
88.77
26
A
ASP
9
60.45
83.54
26
A
SER
26
-135.69
-66.13
26
A
LYS
56
-58.28
-174.05
26
A
ASP
57
-95.55
-64.49
26
A
PRO
67
-75.76
-88.23
26
A
VAL
68
179.48
161.61
26
A
ALA
70
-69.61
-70.60
27
A
SER
4
60.57
84.15
27
A
TRP
5
-170.53
89.28
27
A
ASP
9
-150.64
83.97
27
A
LYS
10
-154.63
32.43
27
A
CYS
12
64.39
138.91
27
A
SER
26
-108.95
-66.85
27
A
SER
32
-86.27
-89.66
27
A
GLN
33
177.13
-37.99
27
A
LYS
56
-60.45
-175.75
27
A
PRO
67
-77.66
-81.95
27
A
VAL
68
164.64
156.33
27
A
THR
69
-60.79
99.58
28
A
SER
4
55.25
176.09
28
A
ASP
9
60.69
104.75
28
A
CYS
12
60.90
101.77
28
A
SER
26
-121.54
-64.08
28
A
LYS
37
-152.99
88.39
28
A
LYS
56
-58.55
-177.54
28
A
PRO
67
-76.05
-82.77
28
A
VAL
68
177.82
170.96
29
A
ALA
3
-176.85
123.00
29
A
ASP
9
60.93
110.80
29
A
CYS
12
37.28
97.17
29
A
SER
26
-123.64
-66.95
29
A
CYS
35
-118.50
-74.72
29
A
SER
36
-179.31
-46.34
29
A
LYS
37
-167.63
63.87
29
A
LYS
56
-64.39
-172.51
29
A
PRO
67
-79.00
-78.55
29
A
VAL
68
178.76
163.41
30
A
TRP
5
-177.73
-40.66
30
A
ARG
7
60.49
89.32
30
A
CYS
11
57.40
-174.29
30
A
CYS
12
-170.35
112.81
30
A
LYS
17
85.84
-44.11
30
A
SER
27
-177.30
-171.81
30
A
THR
31
-69.48
-176.22
30
A
SER
32
-77.69
-89.53
30
A
GLN
33
177.11
-37.49
30
A
PRO
67
-77.75
-86.96
30
A
VAL
68
176.32
152.00
30
A
ALA
70
-157.51
-70.65
31
A
ARG
7
60.40
86.41
31
A
ASP
9
-78.32
-70.76
31
A
LYS
10
-177.52
88.76
31
A
CYS
12
60.11
159.62
31
A
SER
26
-102.74
-67.18
31
A
LYS
37
-151.64
75.85
31
A
LYS
56
-63.56
-172.46
31
A
PRO
67
-78.83
-78.27
31
A
VAL
68
172.46
163.64
32
A
ALA
3
-148.21
-49.15
32
A
ASP
9
60.66
85.62
32
A
CYS
12
61.08
110.24
32
A
LYS
17
88.07
-42.22
32
A
SER
26
-131.08
-67.40
32
A
PRO
67
-74.25
-89.17
32
A
ALA
70
60.64
159.22
33
A
TRP
5
-142.69
32.91
33
A
HIS
6
-102.82
-70.66
33
A
SER
26
-109.90
-67.01
33
A
GLN
33
-103.00
40.86
33
A
LEU
34
-152.37
41.14
33
A
SER
36
71.34
-63.23
33
A
LYS
56
-60.20
-173.40
33
A
ASP
57
-99.10
-62.04
33
A
PRO
67
-79.36
-78.73
33
A
VAL
68
170.04
144.38
34
A
TRP
5
-132.99
-73.87
34
A
ARG
7
60.26
87.99
34
A
CYS
12
65.89
119.22
34
A
GLN
33
-99.59
30.49
34
A
CYS
35
-60.13
-172.85
34
A
LYS
56
-56.82
-176.19
34
A
PRO
67
-77.14
-85.22
34
A
VAL
68
178.18
141.65
34
A
THR
69
41.07
95.13
35
A
TRP
5
-150.89
-67.84
35
A
HIS
6
-178.75
120.88
35
A
ARG
7
60.36
81.19
35
A
LYS
10
-177.64
95.85
35
A
CYS
12
61.26
84.99
35
A
LYS
17
86.69
-41.98
35
A
GLN
33
-93.86
48.24
35
A
LEU
34
-150.40
32.74
35
A
LYS
56
-59.88
-173.16
35
A
ASP
57
-99.64
-61.94
35
A
PRO
67
-75.99
-82.51
35
A
VAL
68
179.77
172.43
35
A
ALA
70
60.68
162.61
36
A
ALA
3
-164.55
-46.16
36
A
SER
4
-172.01
103.30
36
A
HIS
6
-140.57
-47.96
36
A
ASP
9
-177.57
85.82
36
A
CYS
11
-61.53
-178.05
36
A
LYS
17
87.35
-42.94
36
A
GLN
33
-94.96
45.75
36
A
LEU
34
-150.55
47.30
36
A
LYS
37
-170.00
79.43
36
A
ALA
52
-170.19
126.77
36
A
ASP
53
-65.27
-175.56
36
A
LYS
56
-57.88
-178.21
36
A
PRO
67
-78.02
-84.36
36
A
VAL
68
174.83
135.58
36
A
ALA
70
-161.01
32.73
37
A
SER
4
60.56
167.61
37
A
CYS
11
58.14
165.74
37
A
LYS
17
87.03
-43.40
37
A
PRO
38
-79.26
-166.90
37
A
LYS
56
-57.38
-174.24
37
A
ASP
57
-102.32
-60.12
37
A
PRO
67
-77.07
-78.11
37
A
VAL
68
175.60
143.92
37
A
ALA
70
-169.86
-59.43
38
A
ALA
3
-135.79
-53.15
38
A
SER
4
-176.56
-70.96
38
A
ARG
7
60.47
64.72
38
A
LYS
10
-98.91
-72.23
38
A
CYS
11
-61.99
-175.50
38
A
CYS
12
177.83
126.09
38
A
LYS
17
87.60
-42.60
38
A
SER
26
-126.14
-66.54
38
A
LYS
56
-59.79
-174.23
38
A
ASP
57
-101.35
-60.12
38
A
PRO
67
-78.64
-78.78
38
A
VAL
68
171.63
160.40
38
A
ALA
70
60.61
87.66
VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
NMR solution structures of vMIP-II 1-71 from Kaposi's sarcoma-associated herpesvirus.
1
N
N
A
ASP
57
A
ASP
57
HELX_P
A
LEU
66
A
LEU
66
1
1
10
disulf
2.018
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
35
A
SG
CYS
35
1_555
disulf
2.019
A
CYS
12
A
SG
CYS
12
1_555
A
CYS
51
A
SG
CYS
51
1_555
CHEMOKINE
CHEMOKINE, CXCR4, ANATAGONIST, VMIP-II
VMI2_KSHV
UNP
1
Q98157
24
94
1HFN
1
71
Q98157
A
1
1
71
3
anti-parallel
anti-parallel
A
SER
27
A
SER
27
A
PRO
30
A
PRO
30
A
VAL
40
A
VAL
40
A
LEU
43
A
LEU
43
A
GLN
49
A
GLN
49
A
ALA
52
A
ALA
52
1
P 1